Right after a heart attack, the risk of having another one is very high. This is the most dangerous time for your heart. Blood vessels are still fragile and more likely to form dangerous clots. That’s ...

Eli Lilly & Co. warned that the active ingredient in its weight-loss blockbuster Zepbound could pose a risk to patients when ...

A growing body of medical evidence reveals that certain widely prescribed medication combinations may be silently stealing memories from millions of Americans who remain completely unaware of the ...

Epcoritamab combo reduced the risk of disease progression or death by 79% in the Phase 3 FL trial. Genmab raised its 2025 revenue outlook to $3.5–$3.7 billion after Q2 beat and 19% Y/Y growth. Up Next ...

Eli Lilly and Co LLY on Thursday issued a public warning about potential safety risks linked to compounded tirzepatide ...

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the ...

Polysubstance use has become a defining feature of the U.S. overdose crisis in the past decade. While not every overdose involves multiple substances, a significant and growing proportion includes ...

Silvia Maioli receives funding from The Swedish Research Council, Alzheimerfonden, King Gustaf V:s and Queen Victorias Foundation, The private initiative "Innovative ways to fight Alzheimer´s disease ...

Those with prostate cancer that returns after surgery or radiation—and typically face a high risk of the disease spreading and death—could benefit from a new drug combination. A Cedars-Sinai Medical ...

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...